This article was originally published on TipRanks.com Biopharmaceutical company Sorrento Therapeutics, Inc.
This article was originally published on TipRanks.com.
Shares of the biopharmaceutical company Sorrento Therapeutics (SRNE) jumped 5.1% in Friday’s extended trading session after the company inked a research collaboration agreement …
Sorrento Therapeutics’ subsidiary, Scilex Holding, has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) …
Shares of Sorrento Therapeutics increased 3.3% to close at $8.
Shares in Sorrento rose 2.7% in Monday’s extended market session after the company entered into an exclusive license agreement with Personalized Stem Cells …
Shares in Sorrento Therapeutics (SRNE) spiked 10.51% in Tuesday’s trading after the company released positive Phase 1b Study results evaluating safety and MTD (maximum …
Sorrento Therapeutics (SRNE) and SmartPharm Therapeutics have now signed a merger agreement for Sorrento to acquire SmartPharm, a gene-encoded therapeutics company developing non-viral …
Sorrento sank 14% in extended market trading after the biotech company announced the ousting of its chief financial officer Jiong Shao. The stock …
Shares in Sorrento Therapeutics (SRNE) edged 5% higher in Friday’s after-hours trading, after the company announced that it has now prepaid in full …
